Balabhaskararao Kancharana

Balabhaskararao Kancharana

Auto-generated profile, based on publicly available information

Balabhaskararao Kancharana

Department of Immunology, St. Jude Children’s Research Hospital

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2021 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
YWYaqiu Wang
Yaqiu Wang
RKRajendra Karki
Rajendra Karki
MZMin Zheng
Min Zheng
BKBalabhaskararao Kancharana
Balabhaskararao Kancharana
SLSangJoon Lee
SangJoon Lee
Thirumala-Devi KannegantiThirumala-Devi Kanneganti
Thirumala-Devi Kanneganti
Programmed cell death (PCD) is essential for the innate immune response, which serves as the first line of defense against pathogens. Caspases regulate PCD, immune responses, and homeostasis. Caspase-8 specifically plays multifaceted roles in PCD pathways including pyroptosis, apoptosis, and necroptosis. However, because caspase-8–deficient mice are embryonically lethal, little is known about how caspase-8 coordinates different PCD pathways under physiological conditions. Here, we report an anti-inflammatory role of caspase-8 during influenza A virus infection. We generated viable mice carrying an uncleavable version of caspase-8 (Casp8DA/DA). We demonstrated that caspase-8 autoprocessing was responsible for activating caspase-3, thereby suppressing gasdermin D–mediated pyroptosis and inflammatory cytokine release. We also found that apoptotic and pyroptotic pathways were activated at the same time during influenza A virus infection, which enabled the cell-intrinsic anti-inflammatory function of the caspase-8–caspase-3 axis. Our findings provide new insight into the immunological consequences of caspase-8–coordinated PCD cross-talk under physiological conditions.

21 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
RMR.K. Subbarao Malireddi
R.K. Subbarao Malireddi
RBRatnakar Bynigeri
Ratnakar Bynigeri
BKBalabhaskararao Kancharana
Balabhaskararao Kancharana
BSBhesh Raj Sharma
Bhesh Raj Sharma
ABAmanda R. Burton
Amanda R. Burton
Thirumala-Devi KannegantiThirumala-Devi Kanneganti
Thirumala-Devi Kanneganti
Interleukin 1α (IL-1α) and IL-1β are the founding members of the IL-1 cytokine family, and these innate immune inflammatory mediators are critically important in health and disease. Early studies on these molecules suggested that their expression was interdependent, with an initial genetic model of IL-1α depletion, the IL-1α KO mouse ( Il1a -KO line1 ), showing reduced IL-1β expression. However, studies using this line in models of infection and inflammation resulted in contrasting observations. To overcome the limitations of this genetic model, we have generated and characterized a new line of IL-1α KO mice ( Il1a -KO line2 ) using CRISPR-Cas9 technology. In contrast to cells from the Il1a -KO line1 , where IL-1β expression was drastically reduced, bone marrow-derived macrophages (BMDMs) from Il1a -KO line2 mice showed normal induction and activation of IL-1β. Additionally, Il1a -KO line2 BMDMs showed normal inflammasome activation and IL-1β expression in response to multiple innate immune triggers, including both pathogen-associated molecular patterns and pathogens. Moreover, using Il1a -KO line2 cells, we confirmed that IL-1α, independent of IL-1β, is critical for the expression of the neutrophil chemoattractant KC/CXCL1. Overall, we report the generation of a new line of IL-1α KO mice and confirm functions for IL-1α independent of IL-1β. Future studies on the unique functions of IL-1α and IL-1β using these mice will be critical to identify new roles for these molecules in health and disease and develop therapeutic strategies.